Locations:
Search
The decision to use 223-radium, and an outcome that exceeded expectations
Physicians shares insights about screening, supportive care and potential therapies in development
Focus is exocrine pancreatic stem cell development
New findings about the drug’s safety and efficacy from a phase II trial
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Seth Rotz, MD, joins the Cancer Advances podcast to share insights
A 12-year-old patient and others in clinical trial are cured of sickle cell disease thanks to half-match donors
Combination therapy shows promise in pediatric patient population
What pediatric cancer centers can do to improve access to patients
Key findings from national database study
Recommendations reflect weak evidence, unnecessary risks or high costs
Advertisement
Advertisement